2017-4

SUBJECT INDEX 2017
34 th Volume Index / 34. Cilt Dizini
SUBJECT INDEX - KONU DİZİNİ 2017
Acute Leukemia
Relapsed/refractory leukemia / Nüks/refrakter lösemi, 46
FLAG regimen / FLAG tedavisi, 46
Chemotherapy / Kemoterapi, 46
Childhood / Çocukluk çağı, 46
Hypogammaglobulinemia / Hipogamaglobulinemi, 89
Leukemia / Lösemi, 89, 109, 126, 186, 190
Lymphoma / Lenfoma, 89
Myeloma / Miyelom, 89, 181, 182
Vancomycin-resistant Enterococcus / Vankomisin dirençli entekok, 89
Wernicke’s encephalopathy / Wernicke ensefalopatisi, 99
Thiamine deficiency / Tiamin eksikliği, 99
Pediatric leukemia / Pediatrik lösemi, 99, 340
Trisomy 6 / Trizomi 6, 103
Acute myeloid leukemia / Akut miyeloid lösemi, 103, 192, 340, 300, 307
Breast cancer / Meme kanseri, 103
Granulocytic sarcoma / Granülositik sarkom, 122
Acute monoblastic leukemia / Akut monoblastik lösemi, 122
CD34 / CD34, 122
Myeloperoxidase / Miyeloperoksidaz, 122
Monosomal karyotype / Monozomal karyotip, 126
Prognosis / Prognoz, 126, 143, 207
Methotrexate / Metotreksat, 143
Toxicity / Toksisite, 143
Folate-related gene polymorphisms / Folat-ilişkili gen
polimorfizmleri, 143
Acute lymphoblastic leukemia / Akut lenfoblastik lösemi, 40, 151, 366
Glucocorticoid receptor gene / Glukokortikoid reseptör geni, 151
BclI and N363S polymorphisms / BclI ve N363S polimorfizmler, 151
TET2 / TET2, 174
ASXL1 / ASXL1, 174
IDH1 / IDH1, 174
IDH2 / IDH2, 174
Single nucleotide polymorphisms / Tek nükleoitid polimorfizm, 174
Ph-negative myeloproliferative neoplasms / Ph-negatif
Miyeloproliferatif neoplaziler, 174
Granulocytic sarcoma / Granülositik sarkom, 190
Lymphadenopathy / Lenfadenopati, 190
Azacitidine / Azasitidin, 192
Leukemia cutis / Lösemi kutis, 192
Febrile neutropenia / Netropenik Ateş, 109, 167, 254, 340
Infection / Enfeksiyon, 340
Acute myelogenous leukemia / Akut myeloid lösemi, 350
Bullous pyoderma gangrenosum / Büllöz piyoderma gangrenosum, 350
Pathergy / Paterji, 350
EZH2 / EZH2, 366
Adult / Erişkin, 366
T-cell / T-hücre, 366
Gene mutation / Gen mutasyonu, 300
FLT3 / FLT3, 300
NPM1 / NPM1, 300
Autoantibody / Otoantikor, 307
Cancer / Kanser, 307
Carbonic anhydrase / Karbonik anhidraz, 307
Anemia
Schistocyte / Şistosit, 59
Thrombotic microangiopathy / Trombotik mikroanjiopati, 59
Microscopy / Mikroskop, 59
ADVIA 2120 / ADVIA 2120, 59
Standardization / Standardizasyon, 59
Refractory anemia with ring sideroblasts / Halka sideroblastlı
refrakter anemi, 100
RARS with thrombocytosis / Trombositoz ile birlikte RARS, 100
Myelodysplastic syndrome/myeloproliferative neoplasm with
ring sideroblasts and thrombocytosis / Halka sideroblast ve trombositoz
ile birlikte miyelodisplastik sendrom/miyeloproliferatif neoplaz, 100
Abnormal hemoglobins / Anormal hemoglobinler, 114
Hb Kansas / Hb Kansas 114
Children / Çocuk, 120
Griscelli syndrome / Griscelli sendromu, 120
Status epilepticus / Status epileptikus, 120
Hemophagocytic lymphohistiocytosis / Hemofagositik
lenfohistiyositoz, 120
Adult / Erişkin, 196, 366
Sickle cell anemia / Orak hücreli anemi, 196, 358
Genetic counseling / Genetik danışmanlık, 196
Transplantation / Transplantasyon, 102, 196, 345
Blood components / Kan içeriği, 244
Blood processing / Kan ürünlerini işleme, 244
Donors / Verici, 244
Transfusion strategy / Transfüzyon stratejisi, 244
Thalassemia / Talasemi, 258
Sickle/β-thalassemia / Orak/β talasemi, 258
Codon / Kodon, 258
Genotype / Genotip, 258
Phenotype / Fenotip, 258
Osteomyelitis / Osteomiyelit, 358
Salmonella typhi / Salmonella typhi, 358
Myopathy / Miyopati, 376
Lactic acidosis / Laktik asidoz, 376
Sideroblastic anemia / Sideroblastik anemi, 376
Hidden blood loss / Gizli kan kaybı, 334
Antioxidants / Antioksidanlar, 334
Proanthocyanidin / Proantosiyanidin, 334
Hydrogen water / Hidrojenli su, 334
Bleeding Disorders
Hemophilia A / Hemofili A, 113
Intradiploic hematoma / İntradiploik hematom, 113
Coagulopathy / Koagülopati, 113
Intraosseous / İntraosseoz, 113
Children / Çocuk, 120
Griscelli syndrome / Griscelli sendromu, 120